Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 27,600 shares at $178.90 ($4.8M) on 2021-09-13, disclosed to the SEC on 2021-09-15.
Open-market sale of $4.8M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.06 | 2,300 | $389K | 8.1% |
| 2 | $170.30 | 1,300 | $221K | 4.6% |
| 3 | $170.30 | 1,300 | $221K | 4.6% |
| 4 | $171.20 | 300 | $51K | 1.1% |
| 5 | $172.40 | 400 | $69K | 1.4% |
| 6 | $174.14 | 2,700 |
| $470K |
| 9.8% |
| 7 | $174.14 | 2,700 | $470K | 9.8% |
| 8 | $175.17 | 2,694 | $472K | 9.8% |
| 9 | $175.17 | 2,694 | $472K | 9.8% |
| 10 | $176.19 | 3,906 | $688K | 14.3% |
| 11 | $176.19 | 3,906 | $688K | 14.3% |
| 12 | $177.21 | 1,700 | $301K | 6.3% |
| 13 | $178.24 | 1,000 | $178K | 3.7% |
| 14 | $178.90 | 500 | $89K | 1.9% |
| 15 | $181.24 | 100 | $18K | 0.4% |
| 16 | $184.32 | 100 | $18K | 0.4% |
| Total | $174.57 avg | 27,600 | $4.8M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |